Notably, the hypermethylated ZNF671 marker holds considerable promise in distinguishing between bladder cancer and non-BCa urine samples by the tree structure, achieving a 92.7% probability (Figure 4b). Here, ZNF671 is linked to urinary bladder carcinoma.